SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
May 9, 2001
ADVANCED NUTRACEUTICALS, INC.
----------------------------------------------------------
(Exact name of registrant as specified in its charter)
Texas
----------------------------------------------
(State or other jurisdiction of incorporation)
0-26362 76-0642336
------------------------ ------------------------------------
(Commission File Number) (IRS Employer Identification Number)
9101 Jameel, Suite 180, Houston, TX 77040
----------------------------------------------------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code (713) 460-1976
--------------
ADVANCED NUTRACEUTICALS, INC.
INFORMATION TO BE INCLUDED IN THE REPORT
Item 7. Financial Statements and Exhibits
(c) Exhibits
99.1 News Release issued May 9, 2001.
Item 9. Regulation FD Disclosure
The News Release issued May 9, 2001 is attached as Exhibit 99.1
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
ADVANCED NUTRACEUTICALS, INC.
Dated: May 9, 2001 By: /s/ Gregory Pusey
--------------------------------------------
Gregory Pusey, President
- 2 -